Global Cell and Gene Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting foreign genes into appropriate recipient cells of patients through gene transfer technology, so that the products made by foreign genes can treat certain diseases. Broadly speaking, gene therapy can also include measures and new technologies taken from the DNA level to treat certain diseases. Cell therapy is a brand-new drug development model. In this type of therapy, immune cell therapy has proved to have the most potential. Now researchers have demonstrated its clinical benefits in the treatment of cancer and infectious diseases, and these There are many different characteristics between therapy and traditional therapy, including its ability to expand and contract as needed, and to adjust the therapeutic effect of the body within a few months or years after a single application; due to basic immunology, gene function, gene editing With the continuous application and progress of synthetic biology, the complexity of immune cell therapy has been greatly expanded, which can improve the effectiveness and safety of immune cell therapy, and also increase its potential for treating diseases.
LPI (LP Information)' newest research report, the “Cell and Gene Therapy Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy sales for 2023 through 2029. With Cell and Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell and Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy.
The global Cell and Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell and Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell and Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell and Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell and Gene Therapy players cover Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc., Human Stem Cells Institute, Kite Pharma, Inc., Kolon TissueGene, Inc., Novartis AG and Orchard Therapeutics plc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gene therapy (gene therapy) refers to the introduction of foreign normal genes into target cells to correct or compensate for diseases caused by defects and abnormal genes in order to achieve therapeutic purposes. It also includes the application of technology such as transgenes, that is, inserting foreign genes into appropriate recipient cells of patients through gene transfer technology, so that the products made by foreign genes can treat certain diseases. Broadly speaking, gene therapy can also include measures and new technologies taken from the DNA level to treat certain diseases. Cell therapy is a brand-new drug development model. In this type of therapy, immune cell therapy has proved to have the most potential. Now researchers have demonstrated its clinical benefits in the treatment of cancer and infectious diseases, and these There are many different characteristics between therapy and traditional therapy, including its ability to expand and contract as needed, and to adjust the therapeutic effect of the body within a few months or years after a single application; due to basic immunology, gene function, gene editing With the continuous application and progress of synthetic biology, the complexity of immune cell therapy has been greatly expanded, which can improve the effectiveness and safety of immune cell therapy, and also increase its potential for treating diseases.
LPI (LP Information)' newest research report, the “Cell and Gene Therapy Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy sales for 2023 through 2029. With Cell and Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell and Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy.
The global Cell and Gene Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell and Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell and Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell and Gene Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell and Gene Therapy players cover Amgen Inc., bluebird bio, Inc., Dendreon Pharmaceuticals LLC., Fibrocell Science, Inc., Human Stem Cells Institute, Kite Pharma, Inc., Kolon TissueGene, Inc., Novartis AG and Orchard Therapeutics plc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Rare Diseases
- Oncology
- Hematology
- Cardiovascular
- Ophthalmology
- Neurology
- Other Therapeutic Classes
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutions
- Contract Research Organizations (CROs)
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen Inc.
- bluebird bio, Inc.
- Dendreon Pharmaceuticals LLC.
- Fibrocell Science, Inc.
- Human Stem Cells Institute
- Kite Pharma, Inc.
- Kolon TissueGene, Inc.
- Novartis AG
- Orchard Therapeutics plc.
- Organogenesis Holdings Inc.
- Pfizer, Inc.
- RENOVA THERAPEUTICS
- Shanghai Sunway Biotech Co., Ltd.,
- Sibiono GeneTech Co. Ltd.,
- Spark Therapeutics, Inc.
- Vericel Corporation
- ViroMed Co., Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Market Size 2018-2029
2.1.2 Cell and Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell and Gene Therapy Segment by Type
2.2.1 Rare Diseases
2.2.2 Oncology
2.2.3 Hematology
2.2.4 Cardiovascular
2.2.5 Ophthalmology
2.2.6 Neurology
2.2.7 Other Therapeutic Classes
2.3 Cell and Gene Therapy Market Size by Type
2.3.1 Cell and Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Cell and Gene Therapy Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Research and Academic Institutions
2.4.3 Contract Research Organizations (CROs)
2.4.4 Hospital
2.4.5 Others
2.5 Cell and Gene Therapy Market Size by Application
2.5.1 Cell and Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
3 CELL AND GENE THERAPY MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Cell and Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Cell and Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY BY REGIONS
4.1 Cell and Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Cell and Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Cell and Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Cell and Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell and Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cell and Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Cell and Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Cell and Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Cell and Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Cell and Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy by Country (2018-2023)
7.2 Europe Cell and Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Cell and Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Cell and Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell and Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY MARKET FORECAST
10.1 Global Cell and Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Cell and Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Cell and Gene Therapy Forecast
10.1.3 APAC Cell and Gene Therapy Forecast
10.1.4 Europe Cell and Gene Therapy Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy Forecast
10.2 Americas Cell and Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Cell and Gene Therapy Market Forecast
10.2.2 Canada Cell and Gene Therapy Market Forecast
10.2.3 Mexico Cell and Gene Therapy Market Forecast
10.2.4 Brazil Cell and Gene Therapy Market Forecast
10.3 APAC Cell and Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Cell and Gene Therapy Market Forecast
10.3.2 Japan Cell and Gene Therapy Market Forecast
10.3.3 Korea Cell and Gene Therapy Market Forecast
10.3.4 Southeast Asia Cell and Gene Therapy Market Forecast
10.3.5 India Cell and Gene Therapy Market Forecast
10.3.6 Australia Cell and Gene Therapy Market Forecast
10.4 Europe Cell and Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Cell and Gene Therapy Market Forecast
10.4.2 France Cell and Gene Therapy Market Forecast
10.4.3 UK Cell and Gene Therapy Market Forecast
10.4.4 Italy Cell and Gene Therapy Market Forecast
10.4.5 Russia Cell and Gene Therapy Market Forecast
10.5 Middle East & Africa Cell and Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Cell and Gene Therapy Market Forecast
10.5.2 South Africa Cell and Gene Therapy Market Forecast
10.5.3 Israel Cell and Gene Therapy Market Forecast
10.5.4 Turkey Cell and Gene Therapy Market Forecast
10.5.5 GCC Countries Cell and Gene Therapy Market Forecast
10.6 Global Cell and Gene Therapy Forecast by Type (2024-2029)
10.7 Global Cell and Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Information
11.1.2 Amgen Inc. Cell and Gene Therapy Product Offered
11.1.3 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Amgen Inc. Main Business Overview
11.1.5 Amgen Inc. Latest Developments
11.2 bluebird bio, Inc.
11.2.1 bluebird bio, Inc. Company Information
11.2.2 bluebird bio, Inc. Cell and Gene Therapy Product Offered
11.2.3 bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 bluebird bio, Inc. Main Business Overview
11.2.5 bluebird bio, Inc. Latest Developments
11.3 Dendreon Pharmaceuticals LLC.
11.3.1 Dendreon Pharmaceuticals LLC. Company Information
11.3.2 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
11.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Dendreon Pharmaceuticals LLC. Main Business Overview
11.3.5 Dendreon Pharmaceuticals LLC. Latest Developments
11.4 Fibrocell Science, Inc.
11.4.1 Fibrocell Science, Inc. Company Information
11.4.2 Fibrocell Science, Inc. Cell and Gene Therapy Product Offered
11.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Fibrocell Science, Inc. Main Business Overview
11.4.5 Fibrocell Science, Inc. Latest Developments
11.5 Human Stem Cells Institute
11.5.1 Human Stem Cells Institute Company Information
11.5.2 Human Stem Cells Institute Cell and Gene Therapy Product Offered
11.5.3 Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Human Stem Cells Institute Main Business Overview
11.5.5 Human Stem Cells Institute Latest Developments
11.6 Kite Pharma, Inc.
11.6.1 Kite Pharma, Inc. Company Information
11.6.2 Kite Pharma, Inc. Cell and Gene Therapy Product Offered
11.6.3 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Kite Pharma, Inc. Main Business Overview
11.6.5 Kite Pharma, Inc. Latest Developments
11.7 Kolon TissueGene, Inc.
11.7.1 Kolon TissueGene, Inc. Company Information
11.7.2 Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
11.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Kolon TissueGene, Inc. Main Business Overview
11.7.5 Kolon TissueGene, Inc. Latest Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Information
11.8.2 Novartis AG Cell and Gene Therapy Product Offered
11.8.3 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Novartis AG Main Business Overview
11.8.5 Novartis AG Latest Developments
11.9 Orchard Therapeutics plc.
11.9.1 Orchard Therapeutics plc. Company Information
11.9.2 Orchard Therapeutics plc. Cell and Gene Therapy Product Offered
11.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Orchard Therapeutics plc. Main Business Overview
11.9.5 Orchard Therapeutics plc. Latest Developments
11.10 Organogenesis Holdings Inc.
11.10.1 Organogenesis Holdings Inc. Company Information
11.10.2 Organogenesis Holdings Inc. Cell and Gene Therapy Product Offered
11.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Organogenesis Holdings Inc. Main Business Overview
11.10.5 Organogenesis Holdings Inc. Latest Developments
11.11 Pfizer, Inc.
11.11.1 Pfizer, Inc. Company Information
11.11.2 Pfizer, Inc. Cell and Gene Therapy Product Offered
11.11.3 Pfizer, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Pfizer, Inc. Main Business Overview
11.11.5 Pfizer, Inc. Latest Developments
11.12 RENOVA THERAPEUTICS
11.12.1 RENOVA THERAPEUTICS Company Information
11.12.2 RENOVA THERAPEUTICS Cell and Gene Therapy Product Offered
11.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 RENOVA THERAPEUTICS Main Business Overview
11.12.5 RENOVA THERAPEUTICS Latest Developments
11.13 Shanghai Sunway Biotech Co., Ltd.,
11.13.1 Shanghai Sunway Biotech Co., Ltd., Company Information
11.13.2 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product Offered
11.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Shanghai Sunway Biotech Co., Ltd., Main Business Overview
11.13.5 Shanghai Sunway Biotech Co., Ltd., Latest Developments
11.14 Sibiono GeneTech Co. Ltd.,
11.14.1 Sibiono GeneTech Co. Ltd., Company Information
11.14.2 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product Offered
11.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Sibiono GeneTech Co. Ltd., Main Business Overview
11.14.5 Sibiono GeneTech Co. Ltd., Latest Developments
11.15 Spark Therapeutics, Inc.
11.15.1 Spark Therapeutics, Inc. Company Information
11.15.2 Spark Therapeutics, Inc. Cell and Gene Therapy Product Offered
11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Spark Therapeutics, Inc. Main Business Overview
11.15.5 Spark Therapeutics, Inc. Latest Developments
11.16 Vericel Corporation
11.16.1 Vericel Corporation Company Information
11.16.2 Vericel Corporation Cell and Gene Therapy Product Offered
11.16.3 Vericel Corporation Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Vericel Corporation Main Business Overview
11.16.5 Vericel Corporation Latest Developments
11.17 ViroMed Co., Ltd.
11.17.1 ViroMed Co., Ltd. Company Information
11.17.2 ViroMed Co., Ltd. Cell and Gene Therapy Product Offered
11.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 ViroMed Co., Ltd. Main Business Overview
11.17.5 ViroMed Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Market Size 2018-2029
2.1.2 Cell and Gene Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell and Gene Therapy Segment by Type
2.2.1 Rare Diseases
2.2.2 Oncology
2.2.3 Hematology
2.2.4 Cardiovascular
2.2.5 Ophthalmology
2.2.6 Neurology
2.2.7 Other Therapeutic Classes
2.3 Cell and Gene Therapy Market Size by Type
2.3.1 Cell and Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
2.4 Cell and Gene Therapy Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Research and Academic Institutions
2.4.3 Contract Research Organizations (CROs)
2.4.4 Hospital
2.4.5 Others
2.5 Cell and Gene Therapy Market Size by Application
2.5.1 Cell and Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
3 CELL AND GENE THERAPY MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Cell and Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Cell and Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY BY REGIONS
4.1 Cell and Gene Therapy Market Size by Regions (2018-2023)
4.2 Americas Cell and Gene Therapy Market Size Growth (2018-2023)
4.3 APAC Cell and Gene Therapy Market Size Growth (2018-2023)
4.4 Europe Cell and Gene Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell and Gene Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cell and Gene Therapy Market Size by Country (2018-2023)
5.2 Americas Cell and Gene Therapy Market Size by Type (2018-2023)
5.3 Americas Cell and Gene Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy Market Size by Region (2018-2023)
6.2 APAC Cell and Gene Therapy Market Size by Type (2018-2023)
6.3 APAC Cell and Gene Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy by Country (2018-2023)
7.2 Europe Cell and Gene Therapy Market Size by Type (2018-2023)
7.3 Europe Cell and Gene Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy by Region (2018-2023)
8.2 Middle East & Africa Cell and Gene Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell and Gene Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY MARKET FORECAST
10.1 Global Cell and Gene Therapy Forecast by Regions (2024-2029)
10.1.1 Global Cell and Gene Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Cell and Gene Therapy Forecast
10.1.3 APAC Cell and Gene Therapy Forecast
10.1.4 Europe Cell and Gene Therapy Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy Forecast
10.2 Americas Cell and Gene Therapy Forecast by Country (2024-2029)
10.2.1 United States Cell and Gene Therapy Market Forecast
10.2.2 Canada Cell and Gene Therapy Market Forecast
10.2.3 Mexico Cell and Gene Therapy Market Forecast
10.2.4 Brazil Cell and Gene Therapy Market Forecast
10.3 APAC Cell and Gene Therapy Forecast by Region (2024-2029)
10.3.1 China Cell and Gene Therapy Market Forecast
10.3.2 Japan Cell and Gene Therapy Market Forecast
10.3.3 Korea Cell and Gene Therapy Market Forecast
10.3.4 Southeast Asia Cell and Gene Therapy Market Forecast
10.3.5 India Cell and Gene Therapy Market Forecast
10.3.6 Australia Cell and Gene Therapy Market Forecast
10.4 Europe Cell and Gene Therapy Forecast by Country (2024-2029)
10.4.1 Germany Cell and Gene Therapy Market Forecast
10.4.2 France Cell and Gene Therapy Market Forecast
10.4.3 UK Cell and Gene Therapy Market Forecast
10.4.4 Italy Cell and Gene Therapy Market Forecast
10.4.5 Russia Cell and Gene Therapy Market Forecast
10.5 Middle East & Africa Cell and Gene Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Cell and Gene Therapy Market Forecast
10.5.2 South Africa Cell and Gene Therapy Market Forecast
10.5.3 Israel Cell and Gene Therapy Market Forecast
10.5.4 Turkey Cell and Gene Therapy Market Forecast
10.5.5 GCC Countries Cell and Gene Therapy Market Forecast
10.6 Global Cell and Gene Therapy Forecast by Type (2024-2029)
10.7 Global Cell and Gene Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Information
11.1.2 Amgen Inc. Cell and Gene Therapy Product Offered
11.1.3 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Amgen Inc. Main Business Overview
11.1.5 Amgen Inc. Latest Developments
11.2 bluebird bio, Inc.
11.2.1 bluebird bio, Inc. Company Information
11.2.2 bluebird bio, Inc. Cell and Gene Therapy Product Offered
11.2.3 bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 bluebird bio, Inc. Main Business Overview
11.2.5 bluebird bio, Inc. Latest Developments
11.3 Dendreon Pharmaceuticals LLC.
11.3.1 Dendreon Pharmaceuticals LLC. Company Information
11.3.2 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
11.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Dendreon Pharmaceuticals LLC. Main Business Overview
11.3.5 Dendreon Pharmaceuticals LLC. Latest Developments
11.4 Fibrocell Science, Inc.
11.4.1 Fibrocell Science, Inc. Company Information
11.4.2 Fibrocell Science, Inc. Cell and Gene Therapy Product Offered
11.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Fibrocell Science, Inc. Main Business Overview
11.4.5 Fibrocell Science, Inc. Latest Developments
11.5 Human Stem Cells Institute
11.5.1 Human Stem Cells Institute Company Information
11.5.2 Human Stem Cells Institute Cell and Gene Therapy Product Offered
11.5.3 Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Human Stem Cells Institute Main Business Overview
11.5.5 Human Stem Cells Institute Latest Developments
11.6 Kite Pharma, Inc.
11.6.1 Kite Pharma, Inc. Company Information
11.6.2 Kite Pharma, Inc. Cell and Gene Therapy Product Offered
11.6.3 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Kite Pharma, Inc. Main Business Overview
11.6.5 Kite Pharma, Inc. Latest Developments
11.7 Kolon TissueGene, Inc.
11.7.1 Kolon TissueGene, Inc. Company Information
11.7.2 Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
11.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Kolon TissueGene, Inc. Main Business Overview
11.7.5 Kolon TissueGene, Inc. Latest Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Information
11.8.2 Novartis AG Cell and Gene Therapy Product Offered
11.8.3 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Novartis AG Main Business Overview
11.8.5 Novartis AG Latest Developments
11.9 Orchard Therapeutics plc.
11.9.1 Orchard Therapeutics plc. Company Information
11.9.2 Orchard Therapeutics plc. Cell and Gene Therapy Product Offered
11.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Orchard Therapeutics plc. Main Business Overview
11.9.5 Orchard Therapeutics plc. Latest Developments
11.10 Organogenesis Holdings Inc.
11.10.1 Organogenesis Holdings Inc. Company Information
11.10.2 Organogenesis Holdings Inc. Cell and Gene Therapy Product Offered
11.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Organogenesis Holdings Inc. Main Business Overview
11.10.5 Organogenesis Holdings Inc. Latest Developments
11.11 Pfizer, Inc.
11.11.1 Pfizer, Inc. Company Information
11.11.2 Pfizer, Inc. Cell and Gene Therapy Product Offered
11.11.3 Pfizer, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Pfizer, Inc. Main Business Overview
11.11.5 Pfizer, Inc. Latest Developments
11.12 RENOVA THERAPEUTICS
11.12.1 RENOVA THERAPEUTICS Company Information
11.12.2 RENOVA THERAPEUTICS Cell and Gene Therapy Product Offered
11.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 RENOVA THERAPEUTICS Main Business Overview
11.12.5 RENOVA THERAPEUTICS Latest Developments
11.13 Shanghai Sunway Biotech Co., Ltd.,
11.13.1 Shanghai Sunway Biotech Co., Ltd., Company Information
11.13.2 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product Offered
11.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Shanghai Sunway Biotech Co., Ltd., Main Business Overview
11.13.5 Shanghai Sunway Biotech Co., Ltd., Latest Developments
11.14 Sibiono GeneTech Co. Ltd.,
11.14.1 Sibiono GeneTech Co. Ltd., Company Information
11.14.2 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product Offered
11.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Sibiono GeneTech Co. Ltd., Main Business Overview
11.14.5 Sibiono GeneTech Co. Ltd., Latest Developments
11.15 Spark Therapeutics, Inc.
11.15.1 Spark Therapeutics, Inc. Company Information
11.15.2 Spark Therapeutics, Inc. Cell and Gene Therapy Product Offered
11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Spark Therapeutics, Inc. Main Business Overview
11.15.5 Spark Therapeutics, Inc. Latest Developments
11.16 Vericel Corporation
11.16.1 Vericel Corporation Company Information
11.16.2 Vericel Corporation Cell and Gene Therapy Product Offered
11.16.3 Vericel Corporation Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Vericel Corporation Main Business Overview
11.16.5 Vericel Corporation Latest Developments
11.17 ViroMed Co., Ltd.
11.17.1 ViroMed Co., Ltd. Company Information
11.17.2 ViroMed Co., Ltd. Cell and Gene Therapy Product Offered
11.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 ViroMed Co., Ltd. Main Business Overview
11.17.5 ViroMed Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell and Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Rare Diseases
Table 3. Major Players of Oncology
Table 4. Major Players of Hematology
Table 5. Major Players of Cardiovascular
Table 6. Major Players of Ophthalmology
Table 7. Major Players of Neurology
Table 8. Major Players of Other Therapeutic Classes
Table 9. Cell and Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Cell and Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Table 12. Cell and Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Cell and Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Table 15. Global Cell and Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Cell and Gene Therapy Revenue Market Share by Player (2018-2023)
Table 17. Cell and Gene Therapy Key Players Head office and Products Offered
Table 18. Cell and Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Cell and Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Cell and Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 23. Global Cell and Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Cell and Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Cell and Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Cell and Gene Therapy Market Size Market Share by Country (2018-2023)
Table 27. Americas Cell and Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Table 29. Americas Cell and Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Table 31. APAC Cell and Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Cell and Gene Therapy Market Size Market Share by Region (2018-2023)
Table 33. APAC Cell and Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Table 35. APAC Cell and Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Table 37. Europe Cell and Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Cell and Gene Therapy Market Size Market Share by Country (2018-2023)
Table 39. Europe Cell and Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Table 41. Europe Cell and Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Cell and Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Cell and Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Cell and Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy
Table 50. Key Market Challenges & Risks of Cell and Gene Therapy
Table 51. Key Industry Trends of Cell and Gene Therapy
Table 52. Global Cell and Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Cell and Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Cell and Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Cell and Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Amgen Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 57. Amgen Inc. Cell and Gene Therapy Product Offered
Table 58. Amgen Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Amgen Inc. Main Business
Table 60. Amgen Inc. Latest Developments
Table 61. bluebird bio, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 62. bluebird bio, Inc. Cell and Gene Therapy Product Offered
Table 63. bluebird bio, Inc. Main Business
Table 64. bluebird bio, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. bluebird bio, Inc. Latest Developments
Table 66. Dendreon Pharmaceuticals LLC. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 67. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
Table 68. Dendreon Pharmaceuticals LLC. Main Business
Table 69. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Dendreon Pharmaceuticals LLC. Latest Developments
Table 71. Fibrocell Science, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 72. Fibrocell Science, Inc. Cell and Gene Therapy Product Offered
Table 73. Fibrocell Science, Inc. Main Business
Table 74. Fibrocell Science, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Fibrocell Science, Inc. Latest Developments
Table 76. Human Stem Cells Institute Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 77. Human Stem Cells Institute Cell and Gene Therapy Product Offered
Table 78. Human Stem Cells Institute Main Business
Table 79. Human Stem Cells Institute Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Human Stem Cells Institute Latest Developments
Table 81. Kite Pharma, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 82. Kite Pharma, Inc. Cell and Gene Therapy Product Offered
Table 83. Kite Pharma, Inc. Main Business
Table 84. Kite Pharma, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Kite Pharma, Inc. Latest Developments
Table 86. Kolon TissueGene, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 87. Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
Table 88. Kolon TissueGene, Inc. Main Business
Table 89. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Kolon TissueGene, Inc. Latest Developments
Table 91. Novartis AG Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 92. Novartis AG Cell and Gene Therapy Product Offered
Table 93. Novartis AG Main Business
Table 94. Novartis AG Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Novartis AG Latest Developments
Table 96. Orchard Therapeutics plc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 97. Orchard Therapeutics plc. Cell and Gene Therapy Product Offered
Table 98. Orchard Therapeutics plc. Main Business
Table 99. Orchard Therapeutics plc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Orchard Therapeutics plc. Latest Developments
Table 101. Organogenesis Holdings Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 102. Organogenesis Holdings Inc. Cell and Gene Therapy Product Offered
Table 103. Organogenesis Holdings Inc. Main Business
Table 104. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Organogenesis Holdings Inc. Latest Developments
Table 106. Pfizer, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 107. Pfizer, Inc. Cell and Gene Therapy Product Offered
Table 108. Pfizer, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 109. Pfizer, Inc. Main Business
Table 110. Pfizer, Inc. Latest Developments
Table 111. RENOVA THERAPEUTICS Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 112. RENOVA THERAPEUTICS Cell and Gene Therapy Product Offered
Table 113. RENOVA THERAPEUTICS Main Business
Table 114. RENOVA THERAPEUTICS Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. RENOVA THERAPEUTICS Latest Developments
Table 116. Shanghai Sunway Biotech Co., Ltd., Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 117. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product Offered
Table 118. Shanghai Sunway Biotech Co., Ltd., Main Business
Table 119. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Shanghai Sunway Biotech Co., Ltd., Latest Developments
Table 121. Sibiono GeneTech Co. Ltd., Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 122. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product Offered
Table 123. Sibiono GeneTech Co. Ltd., Main Business
Table 124. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Sibiono GeneTech Co. Ltd., Latest Developments
Table 126. Spark Therapeutics, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 127. Spark Therapeutics, Inc. Cell and Gene Therapy Product Offered
Table 128. Spark Therapeutics, Inc. Main Business
Table 129. Spark Therapeutics, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Spark Therapeutics, Inc. Latest Developments
Table 131. Vericel Corporation Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 132. Vericel Corporation Cell and Gene Therapy Product Offered
Table 133. Vericel Corporation Main Business
Table 134. Vericel Corporation Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Vericel Corporation Latest Developments
Table 136. ViroMed Co., Ltd. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 137. ViroMed Co., Ltd. Cell and Gene Therapy Product Offered
Table 138. ViroMed Co., Ltd. Main Business
Table 139. ViroMed Co., Ltd. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. ViroMed Co., Ltd. Latest Developments
Table 1. Cell and Gene Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Rare Diseases
Table 3. Major Players of Oncology
Table 4. Major Players of Hematology
Table 5. Major Players of Cardiovascular
Table 6. Major Players of Ophthalmology
Table 7. Major Players of Neurology
Table 8. Major Players of Other Therapeutic Classes
Table 9. Cell and Gene Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Cell and Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Table 12. Cell and Gene Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Cell and Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Table 15. Global Cell and Gene Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Cell and Gene Therapy Revenue Market Share by Player (2018-2023)
Table 17. Cell and Gene Therapy Key Players Head office and Products Offered
Table 18. Cell and Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Cell and Gene Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Cell and Gene Therapy Market Size Market Share by Regions (2018-2023)
Table 23. Global Cell and Gene Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Cell and Gene Therapy Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Cell and Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Cell and Gene Therapy Market Size Market Share by Country (2018-2023)
Table 27. Americas Cell and Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Table 29. Americas Cell and Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Table 31. APAC Cell and Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Cell and Gene Therapy Market Size Market Share by Region (2018-2023)
Table 33. APAC Cell and Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Table 35. APAC Cell and Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Table 37. Europe Cell and Gene Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Cell and Gene Therapy Market Size Market Share by Country (2018-2023)
Table 39. Europe Cell and Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Table 41. Europe Cell and Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Cell and Gene Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Cell and Gene Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Cell and Gene Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy
Table 50. Key Market Challenges & Risks of Cell and Gene Therapy
Table 51. Key Industry Trends of Cell and Gene Therapy
Table 52. Global Cell and Gene Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Cell and Gene Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Cell and Gene Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Cell and Gene Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Amgen Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 57. Amgen Inc. Cell and Gene Therapy Product Offered
Table 58. Amgen Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Amgen Inc. Main Business
Table 60. Amgen Inc. Latest Developments
Table 61. bluebird bio, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 62. bluebird bio, Inc. Cell and Gene Therapy Product Offered
Table 63. bluebird bio, Inc. Main Business
Table 64. bluebird bio, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. bluebird bio, Inc. Latest Developments
Table 66. Dendreon Pharmaceuticals LLC. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 67. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
Table 68. Dendreon Pharmaceuticals LLC. Main Business
Table 69. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Dendreon Pharmaceuticals LLC. Latest Developments
Table 71. Fibrocell Science, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 72. Fibrocell Science, Inc. Cell and Gene Therapy Product Offered
Table 73. Fibrocell Science, Inc. Main Business
Table 74. Fibrocell Science, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Fibrocell Science, Inc. Latest Developments
Table 76. Human Stem Cells Institute Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 77. Human Stem Cells Institute Cell and Gene Therapy Product Offered
Table 78. Human Stem Cells Institute Main Business
Table 79. Human Stem Cells Institute Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Human Stem Cells Institute Latest Developments
Table 81. Kite Pharma, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 82. Kite Pharma, Inc. Cell and Gene Therapy Product Offered
Table 83. Kite Pharma, Inc. Main Business
Table 84. Kite Pharma, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Kite Pharma, Inc. Latest Developments
Table 86. Kolon TissueGene, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 87. Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
Table 88. Kolon TissueGene, Inc. Main Business
Table 89. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Kolon TissueGene, Inc. Latest Developments
Table 91. Novartis AG Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 92. Novartis AG Cell and Gene Therapy Product Offered
Table 93. Novartis AG Main Business
Table 94. Novartis AG Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Novartis AG Latest Developments
Table 96. Orchard Therapeutics plc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 97. Orchard Therapeutics plc. Cell and Gene Therapy Product Offered
Table 98. Orchard Therapeutics plc. Main Business
Table 99. Orchard Therapeutics plc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Orchard Therapeutics plc. Latest Developments
Table 101. Organogenesis Holdings Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 102. Organogenesis Holdings Inc. Cell and Gene Therapy Product Offered
Table 103. Organogenesis Holdings Inc. Main Business
Table 104. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Organogenesis Holdings Inc. Latest Developments
Table 106. Pfizer, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 107. Pfizer, Inc. Cell and Gene Therapy Product Offered
Table 108. Pfizer, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 109. Pfizer, Inc. Main Business
Table 110. Pfizer, Inc. Latest Developments
Table 111. RENOVA THERAPEUTICS Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 112. RENOVA THERAPEUTICS Cell and Gene Therapy Product Offered
Table 113. RENOVA THERAPEUTICS Main Business
Table 114. RENOVA THERAPEUTICS Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. RENOVA THERAPEUTICS Latest Developments
Table 116. Shanghai Sunway Biotech Co., Ltd., Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 117. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product Offered
Table 118. Shanghai Sunway Biotech Co., Ltd., Main Business
Table 119. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Shanghai Sunway Biotech Co., Ltd., Latest Developments
Table 121. Sibiono GeneTech Co. Ltd., Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 122. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product Offered
Table 123. Sibiono GeneTech Co. Ltd., Main Business
Table 124. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Sibiono GeneTech Co. Ltd., Latest Developments
Table 126. Spark Therapeutics, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 127. Spark Therapeutics, Inc. Cell and Gene Therapy Product Offered
Table 128. Spark Therapeutics, Inc. Main Business
Table 129. Spark Therapeutics, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Spark Therapeutics, Inc. Latest Developments
Table 131. Vericel Corporation Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 132. Vericel Corporation Cell and Gene Therapy Product Offered
Table 133. Vericel Corporation Main Business
Table 134. Vericel Corporation Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Vericel Corporation Latest Developments
Table 136. ViroMed Co., Ltd. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 137. ViroMed Co., Ltd. Cell and Gene Therapy Product Offered
Table 138. ViroMed Co., Ltd. Main Business
Table 139. ViroMed Co., Ltd. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. ViroMed Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Cell and Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cell and Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cell and Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Cell and Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cell and Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Cell and Gene Therapy in Pharmaceutical and Biotechnology Companies
Figure 11. Global Cell and Gene Therapy Market: Pharmaceutical and Biotechnology Companies (2018-2023) & ($ Millions)
Figure 12. Cell and Gene Therapy in Research and Academic Institutions
Figure 13. Global Cell and Gene Therapy Market: Research and Academic Institutions (2018-2023) & ($ Millions)
Figure 14. Cell and Gene Therapy in Contract Research Organizations (CROs)
Figure 15. Global Cell and Gene Therapy Market: Contract Research Organizations (CROs) (2018-2023) & ($ Millions)
Figure 16. Cell and Gene Therapy in Hospital
Figure 17. Global Cell and Gene Therapy Market: Hospital (2018-2023) & ($ Millions)
Figure 18. Cell and Gene Therapy in Others
Figure 19. Global Cell and Gene Therapy Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Cell and Gene Therapy Market Size Market Share by Application in 2022
Figure 21. Global Cell and Gene Therapy Revenue Market Share by Player in 2022
Figure 22. Global Cell and Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Cell and Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 24. APAC Cell and Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 25. Europe Cell and Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Cell and Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 27. Americas Cell and Gene Therapy Value Market Share by Country in 2022
Figure 28. United States Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Cell and Gene Therapy Market Size Market Share by Region in 2022
Figure 33. APAC Cell and Gene Therapy Market Size Market Share by Type in 2022
Figure 34. APAC Cell and Gene Therapy Market Size Market Share by Application in 2022
Figure 35. China Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Cell and Gene Therapy Market Size Market Share by Country in 2022
Figure 42. Europe Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 43. Europe Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 44. Germany Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 58. APAC Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Europe Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 61. United States Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Canada Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. China Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Japan Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Korea Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. India Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Australia Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Germany Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. France Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. UK Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Italy Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Russia Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Spain Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 79. Israel Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 82. Global Cell and Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Cell and Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Cell and Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cell and Gene Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cell and Gene Therapy Sales Market Share by Country/Region (2022)
Figure 8. Cell and Gene Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cell and Gene Therapy Market Size Market Share by Type in 2022
Figure 10. Cell and Gene Therapy in Pharmaceutical and Biotechnology Companies
Figure 11. Global Cell and Gene Therapy Market: Pharmaceutical and Biotechnology Companies (2018-2023) & ($ Millions)
Figure 12. Cell and Gene Therapy in Research and Academic Institutions
Figure 13. Global Cell and Gene Therapy Market: Research and Academic Institutions (2018-2023) & ($ Millions)
Figure 14. Cell and Gene Therapy in Contract Research Organizations (CROs)
Figure 15. Global Cell and Gene Therapy Market: Contract Research Organizations (CROs) (2018-2023) & ($ Millions)
Figure 16. Cell and Gene Therapy in Hospital
Figure 17. Global Cell and Gene Therapy Market: Hospital (2018-2023) & ($ Millions)
Figure 18. Cell and Gene Therapy in Others
Figure 19. Global Cell and Gene Therapy Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Cell and Gene Therapy Market Size Market Share by Application in 2022
Figure 21. Global Cell and Gene Therapy Revenue Market Share by Player in 2022
Figure 22. Global Cell and Gene Therapy Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Cell and Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 24. APAC Cell and Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 25. Europe Cell and Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Cell and Gene Therapy Market Size 2018-2023 ($ Millions)
Figure 27. Americas Cell and Gene Therapy Value Market Share by Country in 2022
Figure 28. United States Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Cell and Gene Therapy Market Size Market Share by Region in 2022
Figure 33. APAC Cell and Gene Therapy Market Size Market Share by Type in 2022
Figure 34. APAC Cell and Gene Therapy Market Size Market Share by Application in 2022
Figure 35. China Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Cell and Gene Therapy Market Size Market Share by Country in 2022
Figure 42. Europe Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 43. Europe Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 44. Germany Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Cell and Gene Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 58. APAC Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Europe Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 61. United States Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Canada Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 65. China Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Japan Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Korea Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 69. India Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Australia Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Germany Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 72. France Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 73. UK Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Italy Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Russia Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Spain Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 79. Israel Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Cell and Gene Therapy Market Size 2024-2029 ($ Millions)
Figure 82. Global Cell and Gene Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Cell and Gene Therapy Market Size Market Share Forecast by Application (2024-2029)
